Apart from the BRAF V600E mutation, a common oncogenic mutation is RAS mutation, especially KRAS mutation, which accounts for approximately 40% of CRC cases, and is related to poor prognosis and metastasis (58, 59). Here, KRAS is linked to colorectal carcinoma.